Sign in
TerminatedNo phase

Spinal Cord Stimulation in Hypotensive Heart Failure Patients: Hemodynamic Assessment

Key facts

Who runs it
Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health
Where
Russia1 site in 1 countryChoose a country to see its sites
Trial code
Status
Terminated
People taking part
6 people enrolled
Started
25 Mar 2022
Ended
9 Jan 2024
Type of study
Interventional
Treatments tested
  • Spinal cord stimulation
Record updated
6 March 2024
Why it stopped
No perceivable effect of transcutaneous spinal cord stimulation on blood pressure in heart failure patients

Who can take part

Age
18 years to 75 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • Age 18-75 years
  • Patients with heart failure III-IV functional class (NYHA) with indications to right heart catheterization
  • Systolic blood pressure <110/70 mm Hg when measured while sitting
  • Patient who signed an informed consent form

Who cannot take part

  • Transient ischemic event or stroke within 2 weeks prior to inclusion
  • Any acute illness
  • Epilepsy
  • Hypovolemic status (central venous pressure <2 mm Hg)
  • Pulmonary embolism <1 month ago
  • An implanted infusion pump
  • Pacemaker-dependent patients
  • Patients who have contraindications to the use of the patch electrodes used in this study, as indicated in the respective instructions for use

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This is a prospective single-center study that aims to evaluate the effects of non-invasive transcutaneous spinal cord stimulation on systemic and pulmonary hemodynamics, assessed during right heart catheterization in patients with heart failure and persistent or transient hypotension subjected to be included into the heart transplantation waiting list.

The group in the trial

  • Spinal cord stimulation in heart failure patients with hypotensionTreatment being tested

    Adhesive patches are applied to subjects' back skin. Single stimuli are delivered in order to define the stimulation threshold under the guidance of neuromyography. Vascular access is performed (jugular or subclavian) according to conventional preparation to right heart catheterization. Invasive hemodynamic measures are performed as usual. High-frequency spinal cord stimulation at T5 level is initiated, and repeated hemodynamic measures performed within 2 minutes. Stimulation lasts for 5-10 minutes, and then ceased. Following a 5-minutes waiting period, repeat hemodynamic measures are performed. The same sequence of steps applies for stimulation levels T7-8 and a combination of T5 and T7-8. Then the procedure is completed and data are analysed.

    Treatment: Spinal cord stimulation

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Hemodynamic Effects of Transcutaneous Spinal Cord Stimulation in Patients With Chronic Heart Failure Undergoing Right Heart Catheterization for the Inclusion Into the Heart Transplantation Program: a Pilot Study
Record updated
6 March 2024